THE SEVERE COMBINED IMMUNODEFICIENT MOUSE (CB-17 SCID) - A NEW MODEL FOR HUMAN SKIN-CANCER INVESTIGATION

被引：0
|
作者：
GOSLEN, JB [1 ]
CHARLEY, MR [1 ]
THARP, MD [1 ]
DENG, JS [1 ]
JEGASOTHY, B [1 ]
机构：
[1] UNIV PITTSBURGH,DEPT DERMATOL,PITTSBURGH,PA 15260
来源：
CLINICAL RESEARCH | 1990年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A607 / A607
页数：1
相关论文
共 50 条
  • [21] ENGRAFTMENT AND SURVIVAL OF HUMAN CYTOTOXIC T-LYMPHOCYTE (CTL) CLONES IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MOUSE
    DEKROON, JFEM
    DEPAUS, RA
    WILLEMZE, R
    FALKENBURG, JHF
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1121 - 1121
  • [22] Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model
    Erdag, G
    Morgan, JR
    TRANSPLANTATION, 2002, 73 (04) : 519 - 528
  • [23] Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model
    Alves, F
    Borchers, U
    Padge, B
    Augustin, H
    Nebendahl, K
    Klöppel, G
    Tietze, LF
    CANCER LETTERS, 2001, 165 (02) : 161 - 170
  • [24] Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
    Nemeth, JA
    Harb, JF
    Barroso, U
    He, ZQ
    Grignon, DJ
    Cher, ML
    CANCER RESEARCH, 1999, 59 (08) : 1987 - 1993
  • [25] Successful tumor formation following xenotransplantation of primary human ovarian cancer cells into severe combined immunodeficient (SCID) pigs
    Boettcher, Adeline N.
    Kiupel, Matti
    Adur, Malavika
    Cocco, Emiliano
    Santin, Alessandro
    Charley, Sara
    Risinger, John
    Tuggle, Christopher
    Shapiro, Erik
    CANCER RESEARCH, 2018, 78 (13)
  • [26] HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice
    Valentiner, U
    Hall, DMS
    Brooks, SA
    Schumacher, U
    CANCER LETTERS, 2005, 219 (02) : 233 - 242
  • [27] The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice (vol 101, pg 494, 1995)
    Walker, W
    Gallagher, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01): : 176 - 176
  • [28] Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin
    Murray, AG
    Schechner, JS
    Epperson, DE
    Sultan, P
    McNiff, JM
    Hughes, CCW
    Lorber, MI
    Askenase, PW
    Pober, JS
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (02): : 627 - 638
  • [29] A severe combined immunodeficient-hu In vivo mouse model of human primary mantle cell lymphoma
    Wang, Michael
    Zhang, Liang
    Han, Xiaohong
    Yang, Jing
    Qian, Jianfei
    Hong, Sungyoul
    Lin, Pei
    Shi, Yuankai
    Romaguera, Jorge
    Kwak, Larry W.
    Yi, Qing
    CLINICAL CANCER RESEARCH, 2008, 14 (07) : 2154 - 2160
  • [30] Recombinant mistletoe lectin (rML) is successful in heating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice
    Schumacher, U
    Feldhaus, S
    Mengs, U
    CANCER LETTERS, 2000, 150 (02) : 171 - 175
12345